Literature DB >> 1675060

Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats.

P G Clifton1, I N Rusk, S J Cooper.   

Abstract

In male rats with food and water freely available, the specific dopamine D2 antagonist YM-09151-2 had little effect on total food or water intake across a 24-hr period. However, it produced a substantial dose-related decrease in feeding rate during meals and an enhancement of both meal size and duration. The equivalent parameters for water intake were affected to a much lesser extent. A second dopamine D2 antagonist, remoxipride, had similar effects on feeding patterns and, in addition, raised food intake during the 2 hr after drug administration. A third dopamine D2 antagonist, raclopride, produced a short-lived rise in food intake and a slowing of feeding rate with a nonsignificant increase in meal size at intermediate doses. Higher doses increased the latency to feed and drink. The specific D1 antagonist SCH 23390 had small effects on both total food intake and feeding patterns. Water intake was substantially reduced in the first 2-4 hr after drug administration by an increased latency to drink. The results are interpreted, first of all, in terms of two separate effects of dopamine D2 receptors on feeding behavior: the first mediating positive feedback processes important at meal initiation and the second mediating the preabsorptive effects of food on meal termination. D1 receptors, in contrast, are of greater importance in controlling water intake.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675060     DOI: 10.1037//0735-7044.105.2.272

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  22 in total

1.  Acute withdrawal-related hypophagia elicited by amphetamine is attenuated by pretreatment with selective dopamine D1 or D2 receptor antagonists in rats.

Authors:  Wesley White; Jason D Beyer; Ilsun M White
Journal:  Physiol Behav       Date:  2015-08-07

2.  Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism.

Authors:  Sonja K Billes; Stephanie E Simonds; Michael A Cowley
Journal:  Mol Metab       Date:  2012-07-27       Impact factor: 7.422

3.  Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats.

Authors:  Panayotis K Thanos; Jacob Cho; Ronald Kim; Michael Michaelides; Stefany Primeaux; George Bray; Gene-Jack Wang; Nora D Volkow
Journal:  Behav Brain Res       Date:  2010-10-27       Impact factor: 3.332

Review 4.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

5.  The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.

Authors:  Lila T Worden; Mona Shahriari; Andrew M Farrar; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

6.  Behavioral and neurotransmitter specific roles for the ventral tegmental area in reinforcer-seeking and intake.

Authors:  Cristine L Czachowski; Michael J Delory; Jason D Pope
Journal:  Alcohol Clin Exp Res       Date:  2012-03-20       Impact factor: 3.455

Review 7.  Comparing the effects of food restriction and overeating on brain reward systems.

Authors:  Nicole M Avena; Susan Murray; Mark S Gold
Journal:  Exp Gerontol       Date:  2013-03-25       Impact factor: 4.032

8.  Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.

Authors:  Susana Mingote; Mariana Pereira; Andrew M Farrar; Peter J McLaughlin; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-01-17       Impact factor: 3.533

9.  Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Authors:  Nima Davoodi; Mikhail Kalinichev; Sergei A Korneev; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

10.  Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.

Authors:  Montserrat Victoriano; Dominique Hermier; Patrick C Even; Gilles Fromentin; Jean-François Huneau; Daniel Tomé; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2009-07-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.